Empfehlungen der Eidgenössichen Ernährungskommission zur Vitamin-D-Zufuhr für die Schweizer Bevölkerung

Bischoff‐Ferrari, Heike A.; Keller, Ulrich; Burckhardt, P.; Lötscher, Katharina Quack; Gerber, Beat; l’Allemand, Dagmar; Laimbacher, Josef; Bachmann, M; Rizzoli, René

doi:10.4414/smf.2012.01279

Cited by 7 publications

(20 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As vitamin D deficiency is increasingly being prevalent worldwide 19 with a prevalence of about 50% in the healthy elderly population in Switzerland 20 in-depth knowledge of this contributing factor to disease has important public health implications. 21 Most of this research, however, has focused on outpatients and clinical data on medical inhospital patients are still scarce.…”

Section: Introductionmentioning

confidence: 99%

Vitamin D Deficiency Strongly Predicts Adverse Medical Outcome Across Different Medical Inpatient Populations

et al. 2016

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Vitamin D Deficiency Strongly Predicts Adverse Medical Outcome Across Different Medical Inpatient Populations

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Blood tests for vitamin D can be directly identified in claims data (AL position 1006.00). Medications reimbursed by mandatory insurance and medical claims were used to indicate vitamin D supplementation (ATC A11CB, A11CC, A12AX), and conditions that are indications for vitamin D testing according to Swiss guidelines [8]: renal disease (3+ packages ATC B03XA01, B03XA02, B03XA03, V03AE01, V03AE02, V03AE03, V03AE04), osteoporosis (3+ packages ATC M05BA, M05BB, H05BA,G03XC, M05BX04, H05AA02, M05BX53; or DRG I69; or TARMED 39.2140, 39.2150, 39.2160), epilepsy (3+ packages ATC N03AA, N03AB, N03AF), hyperparathyroidism (3+ packages ATC H05BX01, H05BX02, H05BX04, V03AE02, A02AB01, V03AE07), HIV (3+ packages ATC J05AR) and intake of corticosteroids (3+ packages ATC H02). Pregnancy was identified based on claims related to maternity that are exempt from copayments.…”

Section: Methodsmentioning

confidence: 99%

“…Low serum levels of vitamin D (i.e., 25-hydroxyvitamin D) are a causal factor for fractures [4] and are associated with many other health issues such as heart disease, type 2 diabetes, and dementia [5][6][7]. According to Swiss guidelines, patients with (a high risk of) bone diseases, such as osteoporosis or hyperparathyroidism; older, obese, or dark-skinned people; pregnant and breastfeeding women with risk factors; patients with chronic renal disease, liver failure, malabsorption, granulomatous diseases; and patients who are taking certain drugs (anticonvulsants, glucocorticoids, antiretroviral, and others) should be tested [8]. These conditions justify a blood test, as the risk of seriously low levels is high [9,10].…”

Section: Introductionmentioning

confidence: 99%

“…Discussions should include the intake of vitamin D supplements. Over-the-counter vitamin D has been suggested as appropriate routine prevention in the general population of Switzerland and many other countries; the recommended doses vary mostly between 400 and 800 IU per day [8,11,15]. Other discussion items include the role of finding the right balance between exposure to and protection from the sun, and behavioral changes such as smoking cessation and increased physical activity [16].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Potentially inappropriate testing for vitamin D deficiency: a cross-sectional study in Switzerland

Essig

Merlo

Reich

et al. 2020

BMC Health Serv Res

View full text Add to dashboard Cite

Background There is consensus that vitamin D supplementation is often indicated but population-based screening by laboratory testing for vitamin D deficiency is inadequate. Testing should be restricted to people at high risk of severe deficiency. This study describes the current lab testing for vitamin D deficiency in the adult population of Switzerland. Methods We assessed Swiss health insurance data (SWICA) for incidence of lab testing for vitamin D levels, comparing the years 2015 and 2018. Claims were analyzed for associations between lab testing and age, sex, medical indications, insurance status and geographic location in multivariable regression analyses. We also estimated the costs of vitamin D testing. Results Data from 200,043 and 200,046 persons for 2015 and 2018, respectively, were analyzed. Vitamin D level was tested in 14% of the sample population in 2015 and 20% in 2018. Testing increased by 69% for individuals aged 26–30. Testing was associated with being middle-aged to young senior citizens, female, medical indications (pregnancy, renal disease, osteoporosis, hyperparathyroidism, HIV, glucocorticoid intake), more chronic conditions, having a mandatory insurance with a low deductible, additional insurance coverage, and living in urban areas. We estimate that the total laboratory cost to mandatory insurance was about 90 million Swiss francs in 2018. Conclusions Despite recommendations for routine vitamin D supplementation, vitamin D testing of low risk individuals is common and increasing in Switzerland.

show abstract

“…Es gilt aber zu bedenken, dass der Schwellenwert und die empfohlene Vitamin-D-Zufuhr des IOM für die Gesundheit der allgemeinen Bevölkerung ("public health") gilt und die Empfehlung der anderer Fachgruppierungen Personen und Patienten mit erhöhtem Risiko (z. B für Osteoporose, Stürzgefährdung) als Ziel hat (25,28,29).…”

Section: Bei Wem Soll Vitamin D Gemessen Werden?unclassified

Sinn und Unsinn der Vitamin-D- Bestimmung

Kraenzlin¹,

Meier²

2015

Osteologie

View full text Add to dashboard Cite

ZusammenfassungIn den letzten Jahren ist das Interesse an Vitamin D stark gestiegen, dies aufgrund der nachgewiesenen Wirkung von Vitamin D auf den Mineralstoffwechsel und die neuromuskulären Funktionen, aber auch aufgrund anderer, pleiotroper Effekte. Die Konsequenz dieses gesteigerten Interesses spiegelt sich in der zunehmenden Verordnung für die Bestimmung des 25(OH)-Vitamin-D-Spiegels wider, um den Vitamin-D-Versorgungsstatus zu erfassen und um über eine allfällige Vitamin-D-Supplementation zu entscheiden. Die 25(OH)D-Messung wird aber durch verschiede Faktoren beeinflusst. Einerseits die Variabilität und die Tatsache, dass andere Vitamin-D-Metaboliten, wie das 3-epimer von 25(OH)D einen gemessenen Wert für das 25(OH)D beeinflussen können. Ein weiterer Störfaktor für die 25(OH)D-Bestimmung kann der Vitamin-D-Metabolit 24,25(OH)2-D sein. Aufgrund dieser Interferenzen und Variabilität der Vitamin-D-Bestimmung ist es nicht erstaunlich, dass unterschiedliche Assays auch unterschiedliche 25(OH)D-Resultate ergeben, was es schwierig macht, einen genauen Schwellenwert für den Vitamin-D-Mangel bzw. für die Vitamin-D-Insuffizienz zu definieren. Aus diesem Grunde sind auch Anstrengungen im Gange, die Vitamin-D-Bestimmung zu standardisieren. Eine liberale Anwendung einer 25(OH)D-Messung ist nicht zu empfehlen. Es scheint aber vernünftig bei Patienten, die ein erhöhtes Risiko für einen Vitamin-D-Mangel, ein erhöhtes Sturz- oder Frakturrisiko aufweisen, das 25(OH)D zu bestimmen.

show abstract

Empfehlungen der Eidgenössichen Ernährungskommission zur Vitamin-D-Zufuhr für die Schweizer Bevölkerung

Cited by 7 publications

References 0 publications

Vitamin D Deficiency Strongly Predicts Adverse Medical Outcome Across Different Medical Inpatient Populations

Vitamin D Deficiency Strongly Predicts Adverse Medical Outcome Across Different Medical Inpatient Populations

Potentially inappropriate testing for vitamin D deficiency: a cross-sectional study in Switzerland

Sinn und Unsinn der Vitamin-D- Bestimmung

Contact Info

Product

Resources

About